2004, 4th ed., ISBN 9780195111217, xiv, 1016
Book
mAbs, ISSN 1942-0862, 11/2013, Volume 5, Issue 6, pp. 962 - 973
The manufacturing of bispecific antibodies can be challenging for a variety of reasons. For example, protein expression problems, stability issues, or the use...
controlled Fab-arm exchange | bispecific antibodies | large-scale manufacturing | cell culture | purification | scale up | Cell culture | Scale up | Purification | Controlled Fab-arm exchange | Bispecific antibodies | Large-scale manufacturing | MEDICINE, RESEARCH & EXPERIMENTAL | DESIGN | IMMUNOGLOBULIN | MONOCLONAL-ANTIBODY | INTERACTION STRENGTH | CANCER-THERAPY | MOLECULES | CHAIN | GROWTH-FACTOR RECEPTOR | MULTIPLE DISEASE MEDIATORS | Cricetinae | Cricetulus | Enzyme-Linked Immunosorbent Assay | Electrophoresis, Polyacrylamide Gel | Antibodies, Bispecific - biosynthesis | Antibodies, Bispecific - genetics | Point Mutation | Animals | Spectrometry, Mass, Electrospray Ionization | Bioreactors | Protein Engineering | Protein Stability | CHO Cells | Report
controlled Fab-arm exchange | bispecific antibodies | large-scale manufacturing | cell culture | purification | scale up | Cell culture | Scale up | Purification | Controlled Fab-arm exchange | Bispecific antibodies | Large-scale manufacturing | MEDICINE, RESEARCH & EXPERIMENTAL | DESIGN | IMMUNOGLOBULIN | MONOCLONAL-ANTIBODY | INTERACTION STRENGTH | CANCER-THERAPY | MOLECULES | CHAIN | GROWTH-FACTOR RECEPTOR | MULTIPLE DISEASE MEDIATORS | Cricetinae | Cricetulus | Enzyme-Linked Immunosorbent Assay | Electrophoresis, Polyacrylamide Gel | Antibodies, Bispecific - biosynthesis | Antibodies, Bispecific - genetics | Point Mutation | Animals | Spectrometry, Mass, Electrospray Ionization | Bioreactors | Protein Engineering | Protein Stability | CHO Cells | Report
Journal Article
Blood, ISSN 0006-4971, 08/2017, Volume 130, Issue 6, pp. 732 - 741
Recurrent mutations at R140 and R172 in isocitrate dehydrogenase 2 (IDH2) occur in many cancers, including similar to 12% of acute myeloid leukemia (AML). In...
IDH2 MUTATIONS | STEM-CELLS | MUTANT IDH2 | ADULTS | PROGNOSTIC-SIGNIFICANCE | HEMATOLOGY | 2-HYDROXYGLUTARATE | Triazines - pharmacology | Neoplasm Recurrence, Local - metabolism | Triazines - therapeutic use | Leukemia, Myeloid, Acute - pathology | Gene Frequency | Humans | Leukemia, Myeloid, Acute - metabolism | Glutarates - antagonists & inhibitors | Neoplasm Recurrence, Local - drug therapy | Isocitrate Dehydrogenase - genetics | Male | Antineoplastic Agents - therapeutic use | Isocitrate Dehydrogenase - antagonists & inhibitors | Hematopoiesis - drug effects | Neoplasm Recurrence, Local - pathology | Aminopyridines - therapeutic use | Aminopyridines - pharmacology | Leukemia, Myeloid, Acute - drug therapy | Female | Neoplasm Recurrence, Local - genetics | Antineoplastic Agents - pharmacology | Glutarates - metabolism | Mutation | Leukemia, Myeloid, Acute - genetics | Clinical Trials and Observations
IDH2 MUTATIONS | STEM-CELLS | MUTANT IDH2 | ADULTS | PROGNOSTIC-SIGNIFICANCE | HEMATOLOGY | 2-HYDROXYGLUTARATE | Triazines - pharmacology | Neoplasm Recurrence, Local - metabolism | Triazines - therapeutic use | Leukemia, Myeloid, Acute - pathology | Gene Frequency | Humans | Leukemia, Myeloid, Acute - metabolism | Glutarates - antagonists & inhibitors | Neoplasm Recurrence, Local - drug therapy | Isocitrate Dehydrogenase - genetics | Male | Antineoplastic Agents - therapeutic use | Isocitrate Dehydrogenase - antagonists & inhibitors | Hematopoiesis - drug effects | Neoplasm Recurrence, Local - pathology | Aminopyridines - therapeutic use | Aminopyridines - pharmacology | Leukemia, Myeloid, Acute - drug therapy | Female | Neoplasm Recurrence, Local - genetics | Antineoplastic Agents - pharmacology | Glutarates - metabolism | Mutation | Leukemia, Myeloid, Acute - genetics | Clinical Trials and Observations
Journal Article
Journal of Cell Science, ISSN 0021-9533, 03/2018, Volume 131, Issue 5, pp. jcs208397 - jcs208397
ARHGAP19 is a hematopoietic-specific Rho GTPase-activating protein (RhoGAP) that acts through the RhoA/ROCK pathway to critically regulate cell elongation and...
ARHGAP19 | CDK1 | ROCK | Mitosis | Rho GTPase | MGCRACGAP | SIGNALING PATHWAYS | EXCHANGE FACTOR | RHOA | CELL BIOLOGY | CYTOKINESIS | PHASE | ECT2 | EXPRESSION | BINDING | T-LYMPHOCYTES | Phosphorylation | Threonine | Serine | Prophase | Cell division | RhoA protein | Dephosphorylation | Kinases | Cytokinesis | Rho-associated kinase | Hemopoiesis | Proteins | 14-3-3 protein | GTPase-activating protein | Lymphocytes | Metaphase | Docking | Localization | Anaphase | Elongation | Binding sites | Guanosinetriphosphatase
ARHGAP19 | CDK1 | ROCK | Mitosis | Rho GTPase | MGCRACGAP | SIGNALING PATHWAYS | EXCHANGE FACTOR | RHOA | CELL BIOLOGY | CYTOKINESIS | PHASE | ECT2 | EXPRESSION | BINDING | T-LYMPHOCYTES | Phosphorylation | Threonine | Serine | Prophase | Cell division | RhoA protein | Dephosphorylation | Kinases | Cytokinesis | Rho-associated kinase | Hemopoiesis | Proteins | 14-3-3 protein | GTPase-activating protein | Lymphocytes | Metaphase | Docking | Localization | Anaphase | Elongation | Binding sites | Guanosinetriphosphatase
Journal Article
2015, ISBN 9954036202
Le Maroc est probablement l’un des pays d’Afrique du Nord et du Moyen Orient les plus étudiés par les sciences sociales et humaines. Motivée par la diversité...
société | ville | politique | monde rural | rapports sociaux | femme | religion | sociologie | langues | anthropologie | changement social | économie | cultures | droit | territoire
société | ville | politique | monde rural | rapports sociaux | femme | religion | sociologie | langues | anthropologie | changement social | économie | cultures | droit | territoire
eBook
Journal of Chromatography B, ISSN 1570-0232, 06/2016, Volume 1022, pp. 290 - 297
A recent update of the hallmarks of cancer includes metabolism with deregulating cellular energetics. Activating mutations in isocitrate dehydrogenase (IDH)...
Biomarker | Endogenous compounds | Isocitrate dehydrogenase mutations | Oncometabolite | 2-Hydroxyglutaric acid | Liquid tandem mass spectrometry | CHEMISTRY, ANALYTICAL | IDH2 MUTATIONS | BIOCHEMICAL RESEARCH METHODS | DERIVATIZATION | BREAST | L-2-HYDROXYGLUTARATE ENANTIOMERS | D-2-HYDROXYGLUTARATE | Reproducibility of Results | Stereoisomerism | Humans | Leukemia, Myeloid, Acute - metabolism | Linear Models | Glutarates - blood | Biomarkers, Tumor - blood | Sensitivity and Specificity | Biomarkers, Tumor - metabolism | Cell Line, Tumor | Isocitrate Dehydrogenase - metabolism | Glutarates - chemistry | Glutarates - metabolism | Biomarkers, Tumor - chemistry | Chromatography, Liquid - methods | Tandem Mass Spectrometry - methods | Enantiomers | Mass spectrometry | Methods | Enzymes | Deregulation | Diastereomers | Leukemia | Physiological aspects | Liquid chromatography | Mutations | Cellular | Ionization | Blood | Standards
Biomarker | Endogenous compounds | Isocitrate dehydrogenase mutations | Oncometabolite | 2-Hydroxyglutaric acid | Liquid tandem mass spectrometry | CHEMISTRY, ANALYTICAL | IDH2 MUTATIONS | BIOCHEMICAL RESEARCH METHODS | DERIVATIZATION | BREAST | L-2-HYDROXYGLUTARATE ENANTIOMERS | D-2-HYDROXYGLUTARATE | Reproducibility of Results | Stereoisomerism | Humans | Leukemia, Myeloid, Acute - metabolism | Linear Models | Glutarates - blood | Biomarkers, Tumor - blood | Sensitivity and Specificity | Biomarkers, Tumor - metabolism | Cell Line, Tumor | Isocitrate Dehydrogenase - metabolism | Glutarates - chemistry | Glutarates - metabolism | Biomarkers, Tumor - chemistry | Chromatography, Liquid - methods | Tandem Mass Spectrometry - methods | Enantiomers | Mass spectrometry | Methods | Enzymes | Deregulation | Diastereomers | Leukemia | Physiological aspects | Liquid chromatography | Mutations | Cellular | Ionization | Blood | Standards
Journal Article
Journal of Medical Mycology, ISSN 1156-5233, 06/2015, Volume 25, Issue 2, pp. e103 - e104
Original Abstract: Introduction: L'identification de nouvelles cibles pour le developpement de therapies antifongiques efficaces et non toxiques pour les...
Journal Article
Revue Medicale Suisse, ISSN 1660-9379, 03/2016, Volume 12, Issue 511, pp. 606 - 610
Journal Article
9.
Full Text
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
Nature Medicine, ISSN 1078-8956, 08/2018, Volume 24, Issue 8, pp. 1167 - 1177
Mutations in the gene encoding isocitrate dehydrogenase 2 (IDH2) occur in several types of cancer, including acute myeloid leukemia (AML). In model systems,...
MEDICINE, RESEARCH & EXPERIMENTAL | STEM-CELLS | MUTANT IDH2 | PROGNOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE DOMAIN | CELL BIOLOGY | CELL LUNG-CANCER | EVOLUTION | RESISTANCE | CHRONIC LYMPHOCYTIC-LEUKEMIA | MUTATIONS | DIFFERENTIATION | Triazines - pharmacology | Triazines - therapeutic use | Leukemia, Myeloid, Acute - pathology | Neoplastic Stem Cells - drug effects | Humans | Immunophenotyping | Isocitrate Dehydrogenase - antagonists & inhibitors | Mutation - genetics | Neoplasm Recurrence, Local - pathology | Aminopyridines - therapeutic use | Neoplastic Stem Cells - metabolism | Cell Differentiation - drug effects | Hematopoiesis | Aminopyridines - pharmacology | Leukemia, Myeloid, Acute - drug therapy | Neoplastic Stem Cells - pathology | Isocitrate Dehydrogenase - metabolism | Clone Cells | Cohort Studies | Gene mutations | Cell differentiation | Research | Populations | Myeloid leukemia | Leukemia | Cloning | Differentiation (biology) | Patients | Hemopoiesis | Heterogeneity | Inhibitors | Evolution | Mutation | Acute myeloid leukemia | Isocitrate dehydrogenase | Cancer
MEDICINE, RESEARCH & EXPERIMENTAL | STEM-CELLS | MUTANT IDH2 | PROGNOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE DOMAIN | CELL BIOLOGY | CELL LUNG-CANCER | EVOLUTION | RESISTANCE | CHRONIC LYMPHOCYTIC-LEUKEMIA | MUTATIONS | DIFFERENTIATION | Triazines - pharmacology | Triazines - therapeutic use | Leukemia, Myeloid, Acute - pathology | Neoplastic Stem Cells - drug effects | Humans | Immunophenotyping | Isocitrate Dehydrogenase - antagonists & inhibitors | Mutation - genetics | Neoplasm Recurrence, Local - pathology | Aminopyridines - therapeutic use | Neoplastic Stem Cells - metabolism | Cell Differentiation - drug effects | Hematopoiesis | Aminopyridines - pharmacology | Leukemia, Myeloid, Acute - drug therapy | Neoplastic Stem Cells - pathology | Isocitrate Dehydrogenase - metabolism | Clone Cells | Cohort Studies | Gene mutations | Cell differentiation | Research | Populations | Myeloid leukemia | Leukemia | Cloning | Differentiation (biology) | Patients | Hemopoiesis | Heterogeneity | Inhibitors | Evolution | Mutation | Acute myeloid leukemia | Isocitrate dehydrogenase | Cancer
Journal Article
Cancer Discovery, ISSN 2159-8274, 05/2017, Volume 7, Issue 5, pp. 478 - 493
Somatic gain-of-function mutations in isocitrate dehydrogenases (IDH) 1 and 2 are found in multiple hematologic and solid tumors, leading to accumulation of...
HYPERMETHYLATION | ONCOLOGY | MUTANT IDH2 | HEMATOPOIETIC STEM-CELLS | BLOCK | PROGNOSTIC-SIGNIFICANCE | INHIBITOR | ONCOMETABOLITE 2-HYDROXYGLUTARATE | SUFFICIENT | (R)-2-HYDROXYGLUTARATE | HISTONE | Xenograft Model Antitumor Assays | Triazines - pharmacology | Animals | Aminopyridines - pharmacology | Humans | Cell Line, Tumor | Isocitrate Dehydrogenase - genetics | Antineoplastic Agents - pharmacology | Mice | Mutation | Isocitrate Dehydrogenase - antagonists & inhibitors | Leukemia, Myeloid, Acute - genetics
HYPERMETHYLATION | ONCOLOGY | MUTANT IDH2 | HEMATOPOIETIC STEM-CELLS | BLOCK | PROGNOSTIC-SIGNIFICANCE | INHIBITOR | ONCOMETABOLITE 2-HYDROXYGLUTARATE | SUFFICIENT | (R)-2-HYDROXYGLUTARATE | HISTONE | Xenograft Model Antitumor Assays | Triazines - pharmacology | Animals | Aminopyridines - pharmacology | Humans | Cell Line, Tumor | Isocitrate Dehydrogenase - genetics | Antineoplastic Agents - pharmacology | Mice | Mutation | Isocitrate Dehydrogenase - antagonists & inhibitors | Leukemia, Myeloid, Acute - genetics
Journal Article
Journal de Mycologie Médicale, ISSN 1156-5233, 06/2015, Volume 25, Issue 2, pp. e103 - e104
Journal Article
Journal de Mycologie Medicale, ISSN 1156-5233, 06/2015, Volume 25, Issue 2, p. e103-e104
L'identification de nouvelles cibles pour le developpement de therapies antifongiques efficaces et non toxiques pour les cellules humaines reste un defi...
Peptides
Peptides
Journal Article
Journal of Cell Science, ISSN 0021-9533, 01/2014, Volume 127, Issue 2, pp. 400 - 410
Small GTP-binding proteins of the Rho family orchestrate the cytoskeleton remodelling events required for cell division. Guanine nucleotide exchange factors...
Vimentin | Rho GTPases | Rock | Cytokinesis | Lymphocytes | EXCHANGE FACTOR | HUMAN ECT2 | PHOSPHORYLATION | VIMENTIN FILAMENTS | CITRON KINASE | CLEAVAGE FURROW | CELL BIOLOGY | CONTRACTILE RING | CELL-DIVISION | RHOA ACTIVATION | INTERMEDIATE-FILAMENTS | Leukemia - pathology | Oligonucleotide Array Sequence Analysis | Vimentin - metabolism | Humans | Nocodazole - pharmacology | cdc42 GTP-Binding Protein - metabolism | rhoA GTP-Binding Protein - metabolism | Intracellular Signaling Peptides and Proteins - metabolism | Protein Transport - drug effects | GTPase-Activating Proteins - metabolism | Chromosome Segregation - drug effects | Mitosis - genetics | Cell Nucleus - metabolism | Myosin Type II - metabolism | T-Lymphocytes - metabolism | Time Factors | rho-Associated Kinases - metabolism | T-Lymphocytes - drug effects | Prometaphase - drug effects | Cell Membrane - metabolism | Phosphorylation - drug effects | Cell Membrane - drug effects | Leukemia - genetics | Protein-Serine-Threonine Kinases - metabolism | Cytokinesis - drug effects | Gene Expression Regulation, Leukemic - drug effects | Cell Shape - drug effects | Mitosis - drug effects | Signal Transduction - drug effects | T-Lymphocytes - cytology | Cell Line, Tumor | Cell Nucleus - drug effects | rac1 GTP-Binding Protein - metabolism
Vimentin | Rho GTPases | Rock | Cytokinesis | Lymphocytes | EXCHANGE FACTOR | HUMAN ECT2 | PHOSPHORYLATION | VIMENTIN FILAMENTS | CITRON KINASE | CLEAVAGE FURROW | CELL BIOLOGY | CONTRACTILE RING | CELL-DIVISION | RHOA ACTIVATION | INTERMEDIATE-FILAMENTS | Leukemia - pathology | Oligonucleotide Array Sequence Analysis | Vimentin - metabolism | Humans | Nocodazole - pharmacology | cdc42 GTP-Binding Protein - metabolism | rhoA GTP-Binding Protein - metabolism | Intracellular Signaling Peptides and Proteins - metabolism | Protein Transport - drug effects | GTPase-Activating Proteins - metabolism | Chromosome Segregation - drug effects | Mitosis - genetics | Cell Nucleus - metabolism | Myosin Type II - metabolism | T-Lymphocytes - metabolism | Time Factors | rho-Associated Kinases - metabolism | T-Lymphocytes - drug effects | Prometaphase - drug effects | Cell Membrane - metabolism | Phosphorylation - drug effects | Cell Membrane - drug effects | Leukemia - genetics | Protein-Serine-Threonine Kinases - metabolism | Cytokinesis - drug effects | Gene Expression Regulation, Leukemic - drug effects | Cell Shape - drug effects | Mitosis - drug effects | Signal Transduction - drug effects | T-Lymphocytes - cytology | Cell Line, Tumor | Cell Nucleus - drug effects | rac1 GTP-Binding Protein - metabolism
Journal Article
Molecular and Cellular Biology, ISSN 0270-7306, 03/2007, Volume 27, Issue 6, pp. 2324 - 2342
Caprin-1 is a ubiquitously expressed, well-conserved cytoplasmic phosphoprotein that is needed for normal progression through the G(1)-S phase of the cell...
RIBONUCLEOPROTEIN COMPLEXES | PKR | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE | GROWTH | BINDING-PROTEIN | C-MYC | GTPASE-ACTIVATING PROTEIN | IDENTIFICATION | EXPRESSION | ENDORIBONUCLEASE G3BP | CELL BIOLOGY
RIBONUCLEOPROTEIN COMPLEXES | PKR | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE | GROWTH | BINDING-PROTEIN | C-MYC | GTPASE-ACTIVATING PROTEIN | IDENTIFICATION | EXPRESSION | ENDORIBONUCLEASE G3BP | CELL BIOLOGY
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 05/2019, Volume 13, Issue 5, p. e0007268
Background The Zanzibar Elimination of Schistosomiasis Transmission (ZEST) project aimed to eliminate urogenital schistosomiasis as a public health problem...
URINARY SCHISTOSOMIASIS | PRAZIQUANTEL | HEMATOBIUM | PEMBA-ISLAND | SCHOOLCHILDREN | MORBIDITY | PARASITOLOGY | TROPICAL MEDICINE | CHILDREN | Surveys | Schistosomiasis | Praziquantel | Public health | Intervention | Urine | Laboratories | Transmission | Objectives | Trade development | Systematic review | Infections | Museums | Surveying | Epidemiology | Eggs | Tropical diseases | Consortia | Confidence intervals | Students | Adults | Life sciences | Schools | Cross sections
URINARY SCHISTOSOMIASIS | PRAZIQUANTEL | HEMATOBIUM | PEMBA-ISLAND | SCHOOLCHILDREN | MORBIDITY | PARASITOLOGY | TROPICAL MEDICINE | CHILDREN | Surveys | Schistosomiasis | Praziquantel | Public health | Intervention | Urine | Laboratories | Transmission | Objectives | Trade development | Systematic review | Infections | Museums | Surveying | Epidemiology | Eggs | Tropical diseases | Consortia | Confidence intervals | Students | Adults | Life sciences | Schools | Cross sections
Journal Article
RESOURCES FOR AMERICAN LITERARY STUDY, ISSN 0048-7384, 2015, Volume 38, pp. 171 - 171
In 1959, the poet Muriel Rukeyser was asked to write the Christmas issue of the Teacher's Letter, a trade newsletter for educators from Croft Educational...
LITERATURE, AMERICAN
LITERATURE, AMERICAN
Journal Article
ACS Medicinal Chemistry Letters, ISSN 1948-5875, 04/2018, Volume 9, Issue 4, pp. 300 - 305
Somatic point mutations at a key arginine residue (R132) within the active site of the metabolic enzyme isocitrate dehydrogenase 1 (IDH1) confer a novel gain...
AG-120 | mutant IDH1 | ivosidenib | 2-hydroxyglutarate | isocitrate dehydrogenase | differentiation therapy | CHEMISTRY, MEDICINAL | IN-VIVO | MUTATION | ACUTE MYELOID-LEUKEMIA | CELL-DIFFERENTIATION | ENASIDENIB
AG-120 | mutant IDH1 | ivosidenib | 2-hydroxyglutarate | isocitrate dehydrogenase | differentiation therapy | CHEMISTRY, MEDICINAL | IN-VIVO | MUTATION | ACUTE MYELOID-LEUKEMIA | CELL-DIFFERENTIATION | ENASIDENIB
Journal Article
Cancer Research, ISSN 0008-5472, 12/2008, Volume 68, Issue 23, pp. 9601 - 9607
Histone deacetylase inhibitors (HDACi) have been hailed as a powerful new class of anticancer drugs. The HDACi, trichostatin A (TSA), is thought to interfere...
CANCER-CELLS | LUNG-CANCER | MELANOMA | THERAPY | ONCOLOGY | PATHWAY | CARCINOMAS | MECHANISMS | EXPRESSION | ESCAPE | TRICHOSTATIN | Melanoma, Experimental - drug therapy | Antigens, Neoplasm - biosynthesis | RNA Polymerase II - metabolism | ATP-Binding Cassette, Sub-Family B, Member 3 | RNA, Messenger - biosynthesis | T-Lymphocytes, Cytotoxic - drug effects | Melanoma, Experimental - immunology | ATP-Binding Cassette Transporters - genetics | Membrane Transport Proteins - genetics | Histocompatibility Antigens Class I - biosynthesis | Hydroxamic Acids - pharmacology | T-Lymphocytes, Cytotoxic - immunology | Promoter Regions, Genetic | Antigens, Neoplasm - immunology | Mice, Inbred C57BL | RNA, Messenger - genetics | Enzyme Inhibitors - pharmacology | Histocompatibility Antigens Class I - immunology | Antigen Presentation - genetics | ATP-Binding Cassette Transporters - biosynthesis | Membrane Transport Proteins - biosynthesis | Animals | Melanoma, Experimental - genetics | Epigenesis, Genetic - immunology | Cell Line, Tumor | Antigen Presentation - drug effects | Histone Deacetylase Inhibitors | Mice | Membrane Transport Proteins - immunology | ATP-Binding Cassette Sub-Family B Member 2
CANCER-CELLS | LUNG-CANCER | MELANOMA | THERAPY | ONCOLOGY | PATHWAY | CARCINOMAS | MECHANISMS | EXPRESSION | ESCAPE | TRICHOSTATIN | Melanoma, Experimental - drug therapy | Antigens, Neoplasm - biosynthesis | RNA Polymerase II - metabolism | ATP-Binding Cassette, Sub-Family B, Member 3 | RNA, Messenger - biosynthesis | T-Lymphocytes, Cytotoxic - drug effects | Melanoma, Experimental - immunology | ATP-Binding Cassette Transporters - genetics | Membrane Transport Proteins - genetics | Histocompatibility Antigens Class I - biosynthesis | Hydroxamic Acids - pharmacology | T-Lymphocytes, Cytotoxic - immunology | Promoter Regions, Genetic | Antigens, Neoplasm - immunology | Mice, Inbred C57BL | RNA, Messenger - genetics | Enzyme Inhibitors - pharmacology | Histocompatibility Antigens Class I - immunology | Antigen Presentation - genetics | ATP-Binding Cassette Transporters - biosynthesis | Membrane Transport Proteins - biosynthesis | Animals | Melanoma, Experimental - genetics | Epigenesis, Genetic - immunology | Cell Line, Tumor | Antigen Presentation - drug effects | Histone Deacetylase Inhibitors | Mice | Membrane Transport Proteins - immunology | ATP-Binding Cassette Sub-Family B Member 2
Journal Article